Roivant worth
Web18 Feb 2024 · Roivant Sciences has a 52 week low of $2.52 and a 52 week high of $10.00. The firm has a 50 day moving average of $8.14 and a 200 day moving average of $5.68. The company has a debt-to-equity ratio of 0.26, a current ratio of 6.74 and a quick ratio of 7.43. Roivant Sciences (NASDAQ:ROIV - Get Rating Institutional Trading of Roivant Sciences ... Web10 Mar 2024 · Net Worth: $500 Million Date of Birth: Aug 9, 1985 (37 years old) Place of Birth: Cincinnati, Ohio, U.S. 💰 Compare Vivek Ramaswamy's Net Worth
Roivant worth
Did you know?
Web10 Apr 2024 · The stock was sold at an average price of $8.00, for a total value of $96,000,000.00. Following the completion of the transaction, the insider now owns … WebRoivant is expected to receive USD $3 billion from Sumitomo Dainippon Pharma as an upfront payment to enter the Alliance, which includes taking a substantial equity ownership interest in Roivant (over 10% of shares outstanding). About Roivant Sciences
Web14 Mar 2024 · Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch Vants – … Web14 Nov 2024 · Roivant’s newest financing […] Biotech holding company Roivant Sciences raised $200M in funding at a whopping $7B valuation. Connie Loizos @Cookie / 4 years ... For what it’s worth, SoftBank ...
Web1 Jun 2024 · Roivant’s filing tipped off investors that the company was planning to go public, presaging a $7.3 billion SPAC merger last month and prompting speculation over what ... Web3 Apr 2024 · Ramaswamy still owns 7.17 percent of Roivant, worth more than $400 million, and his fortune is worth well over half a billion dollars. To jump-start his presidential bid …
WebRoivant Sciences Ltd. (ROIV) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 7.41 +0.03 (+0.47%) As of 10:53AM EDT. Market open. 1d 5d 1m 6m …
Web22 Feb 2024 · According to a Forbes report in 2016, Ramaswamy's net worth was US $600 million. Dubbed the “CEO of Anti-Woke Inc” by The New Yorker, Ramaswamy is the author … gheorghe marmureanu wikiWeb23 Feb 2024 · Roivant Sciences Ltd.’s market cap currently stands at around $6.10 billion, with investors looking forward to this quarter’s earnings report slated for Feb 13, 2024. … gheorghe mihailWeb26 Sep 2024 · Last month, SoftBank, through its massive Vision Fund, led the single biggest private financing round for a healthcare company ever — funneling $1.1 billion into the … gheorghe miletineanuWeb22 Mar 2024 · Roivant Sciences's market capitalization is $6.66 B by 758.43 M shares outstanding. Roivant Sciences Stock Snapshot 7.26 Bid 12,300.00 Bid Size 7.27 Ask 128,900.00 Ask Size 3/22/2024 Date 8:00... gheorghe mirceaWeb20 Dec 2024 · Roivant has drugs targeting multi-billion dollar autoimmune markets, with one already approved. ... With that said, however, it's worth noting that Takeda believes its … chris wetzel attorney charleston ilWeb22 Feb 2024 · In 2014, Ramaswamy founded Roivant Sciences, a biopharmaceutical company that aims to develop and commercialize innovative therapies for diseases with … chris weydeveldWebGet Roivant Sciences Equity Warrant Exp 30th Sep 2026 (ROIVW:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. chris wewers southern bancorp